Tramadol, pharmacology, side effects, and serotonin syndrome: A review

Pain Physician

Volumn 18, Issue 4, 2015, Pages 395-400

  Beakley, Burton D ^a   Kaye, Adam M ^b   Kaye, Alan D ^a,c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesics; Drug interactions; Serotonin syndrome; Tramadol

Indexed keywords

TRAMADOL; NARCOTIC ANALGESIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGITATION; ANALGESIA; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG OVERDOSE; DRUG USE; FATIGUE; HUMAN; MENTAL HEALTH; NAUSEA AND VOMITING; PAIN; PSYCHOSOCIAL CARE; SEROTONIN SYNDROME; XEROSTOMIA; ANIMAL; CHEMICALLY INDUCED; DRUG INTERACTION; RISK FACTOR;

ANALGESICS, OPIOID; ANIMALS; DRUG INTERACTIONS; HUMANS; RISK FACTORS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; TRAMADOL;

EID: 84938073348     PISSN: 15333159     EISSN: 21501149     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clinical Pharmacokinetics 2004; 43:879-923.
2. Boyer EW, Traub SJ, Grayzel J. Serotonin Syndrome. In: UpToDate. 2015. Accessed 20 May 2015.
3. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352:1112.
4. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96:635-642.
5. Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. The Ochsner Journal 2013; 13:533-540.
6. Fox MA, Jensen CL, Gallager PS, Murphy DL. Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacology 2007; 53:643-656.
7. Benzon H. Practical Management of Pain. 5th ed. Mosby, St. Louis, 2014.
8. Marquardt KA, Alsop JA, Albertson TE. Tramadol exposures reported to statewide posion control system. Ann Phar-macotherapy 2005; 39:1039-1044.
9. Tashakori A, Afshari R. Tramadol overdose as a cause of serotonin syndrome: A case review. Clinical Toxicology 2010; 48:337-341.
10. Ferri F. Ferri's Clinical Advisor 2015. Mos-by, St. Louis, 2014.
11. Igbal MM, Basil MJ, Kaplan J, Igbal MT. Overview of serotonin syndrome. Ann Clinical Psychiatry 2012; 24:310-318.
12. Bronstein AC, Spyker DA, Cantilena LR Jr., Rumack BH, Dart RC. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol (Phila) 2012; 50:911.
13. Park S, Wackernah R, Stimmel G. Serotonin syndrome: Is it a reason to avoid the use of tramadol with antidepres-sants. Journal of Pharmacy Practice 2014; 27:71-78.
14. Mills KC. Serotonin syndrome. A clinical update. Crit Care Clin 1997; 13:763-783.
15. Paar WD, Frankus P, Dengler HJ. The metabolism of tramadol by human liver microsomes. Clin Investig 1992; 70:708-710.
16. Takeshita J, Litzinger M. Serotonin syndrome associated with tramadol. Prim Care Companion J Clin Psychiatry 2009; 11:273.
17. Tashakori A, Afshari R. Tramadol overdose as a cause of serotonin syndrome: A case series. Clin Toxicol (Phila) 2010; 48:337-341.
18. Fox MA, Panessiti MG, Moya PR, Tolliver TJ, Chen K, Shih JC, Murphy DL. Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: Implications for drug side effects in humans. Pharmacogenomics Journal 2013; 13:551-557.
19. Peacock LE, Wright R. Serotonin syndrome secondary to tramadol and cita-lopram. Age Ageing 2011; 40:528.
20. Houlihan DJ. Serotonin syndrome resulting from coadministration of trama-dol, venlafaxine, and mirtazapine. Ann Pharmacotherapy 2004; 38:411-413.
21. Mahlberg R, Kunz D, Sasse J, Kirchheiner J. Serotonin syndrome with tramadol and citalopram. Am J Psychiatry 2004; 161:1129.
22. Lantz MS, Buchalter EN, Giambanco V. Serotonin syndrome following the administration of tramadol with paroxetine therapy. Int Clin Psychopharmacol 1997; 12:181-182.
23. Reimann W, Schneider F. Induction of 5-hydroxytryptamine release by trama-dol, fenfluramine, and reserpine. Eur J Pharmacol 1998; 349:199-203.
24. Shatin D, Gardner JS, Stergachis A, Blough D, Graham D. Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepres-sants. Pharmacoepidemiol Drug Saf 2005; 14:149-154.